⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Free accountRanking, alerts and Top 10Sign up with GoogleSign in

Score changes this week

Analysis of Oct 5, 2026 versus Oct 1, 2026: of 1,289 companies analyzed both times, 550 went up, 245 went down and 494 were unchanged.

Biggest risers

  1. 1ConAgra BrandsCAGConsumer DefensiveThe stock is cheap but the business shows signs of deterioration and leverage limits upside.▲ 0.84.4 → 5.2
  2. 2Fomento Economico MexicanoFMXConsumer DefensiveFundamentals are solid and valuation is reasonable, but governance risk in Mexico warrants some caution.▲ 0.76.5 → 7.2
  3. 3DBSD05.SIFinancial ServicesHold or accumulate DBS, given its solid quality profile and reasonable valuation, although moderate growth limits upside potential.▲ 0.66.5 → 7.1
  4. 4DuPont de NemoursDDBasic MaterialsValuation is attractive but quality and revenue growth do not justify aggressive buying.▲ 0.65.5 → 6.1
  5. 5FactSet Research SystemsFDSFinancial ServicesBusiness quality is high but negative growth and average valuation limit near-term upside potential.▲ 0.66.0 → 6.6
  6. 6FerrovialFER.MCIndustrialsThe combination of high leverage, demanding valuation, and falling earnings makes the risk/reward profile unattractive in the current rising-rate environment, despite the quality of its infrastructure assets.▲ 0.64.1 → 4.7
  7. 7Gildan ActivewearGIL.TOConsumer CyclicalGrowth is strong but cash generation and leverage require monitoring.▲ 0.65.3 → 5.9
  8. 8LennarLENConsumer CyclicalReasonable valuation and stable balance sheet do not offset the sharp earnings decline and weak margin, in an environment where rates continue to pressure housing demand.▲ 0.63.7 → 4.3
  9. 9Micron TechnologyMUTechnologyHold, given the risk of a cyclical peak in semiconductors; wait for growth to normalize before considering an entry.▲ 0.66.4 → 7.0
  10. 10ArgenxARGX.BRHealthcareHold for long-term investors who trust Vyvgart's expansion; avoid for those seeking value or dividend income.▲ 0.56.5 → 7.0

Biggest fallers

  1. 1CortevaCTVABasic MaterialsHold or buy if confidence in the stability of the agricultural inputs business is high; the cheap valuation and high dividend offer a margin of safety, but the scarcity of financial data warrants caution.▼ 1.36.2 → 4.9
  2. 23i GroupIII.LFinancial ServicesThe discount to NAV is attractive, but negative momentum and lack of fundamental data warrant caution before entering.▼ 1.05.9 → 4.9
  3. 3NikeNKEConsumer CyclicalHold, waiting for signs of stabilization in revenue and margins before considering an entry.▼ 0.76.3 → 5.6
  4. 4Standard LifeSDLF.LFinancial ServicesHold only if confident in Aegon integration and margin recovery; current profitability and dividend profile do not justify entry.▼ 0.74.4 → 3.7
  5. 5Neinor HomesHOME.MCReal EstateGrowth and dividend are attractive, but high leverage and unsustainable payout require vigilance, especially if ECB rates continue to rise.▼ 0.65.6 → 5.0
  6. 6Ares CapitalARCCFinancial ServicesThe high dividend partially compensates for earnings deterioration and coverage risk, so it is only suitable for investors with high tolerance for dividend cut risk.▼ 0.56.6 → 6.1
  7. 7CMS EnergyCMSUtilitiesHigh debt and exposure to rising long-term rates limit CMS Energy's appeal despite its dividend.▼ 0.55.8 → 5.3
  8. 8TurkcellTKCCommunication ServicesHold, given the attractive multiple but the elevated governance risk and lack of growth catalysts.▼ 0.55.5 → 5.0
  9. 9CoreWeaveCRWVTechnologyHighly speculative: growth is real but the balance sheet and valuation leave no room for error.▼ 0.43.6 → 3.2
  10. 10CemexCXBasic MaterialsHold, with a positive bias if earnings normalization and improved free cash flow generation are confirmed.▼ 0.45.8 → 5.4

The score sums up, from 0 to 10, what the analysis says about each company. A rise or a fall is not a buy or sell signal: open the company page to see why.
See them all in the stock analysis → · Top 10 scores this week →

General information for educational purposes. Not investment advice.